Senate Bill Would Boost Oversight Of US FDA User Fee Program Following Trump Reorganization

 
• By Sarah Karlin-Smith
  
person in business suit making "eyes on you" signal with hands.
Senate appropriators plan to keep a much closer eye on FDA user fee program spending in their FY 2026 spending bill. (Shutterstock)

More from Legislation

More from Policy & Regulation